Bryan Giraudo - Net Worth and Insider Trading
Bryan Giraudo Net Worth
The estimated net worth of Bryan Giraudo is at least $885,708 dollars as of 2024-05-21. Bryan Giraudo is the Director of Protagonist Therapeutics Inc and owns about 18,000 shares of Protagonist Therapeutics Inc (PTGX) stock worth over $562,680. Bryan Giraudo is also the COO/CFO of Gossamer Bio Inc and owns about 472,747 shares of Gossamer Bio Inc (GOSS) stock worth over $323,028. Details can be seen in Bryan Giraudo's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bryan Giraudo has not made any transactions after 2024-03-27 and currently still holds the listed stock(s).
Transaction Summary of Bryan Giraudo
Bryan Giraudo Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bryan Giraudo owns 2 companies in total, including Gossamer Bio Inc (GOSS) , and Protagonist Therapeutics Inc (PTGX) .
Click here to see the complete history of Bryan Giraudo’s form 4 insider trades.
Insider Ownership Summary of Bryan Giraudo
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GOSS | Gossamer Bio Inc | 2024-03-27 | Chief Financial Officer |
| PTGX | Protagonist Therapeutics Inc | 2022-05-26 | director |
Bryan Giraudo Latest Holdings Summary
Bryan Giraudo currently owns a total of 2 stocks. Among these stocks, Bryan Giraudo owns 18,000 shares of Protagonist Therapeutics Inc (PTGX) as of December 3, 2019, with a value of $562,680 and a weighting of 63.53%. Bryan Giraudo also owns 472,747 shares of Gossamer Bio Inc (GOSS) as of March 27, 2024, with a value of $323,028 and a weighting of 36.47%.
Latest Holdings of Bryan Giraudo
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics Inc | 2019-12-03 | 18,000 | 31.26 | 562,680 |
| GOSS | Gossamer Bio Inc | 2024-03-27 | 472,747 | 0.68 | 323,028 |
Holding Weightings of Bryan Giraudo
Bryan Giraudo Form 4 Trading Tracker
According to the SEC Form 4 filings, Bryan Giraudo has made a total of 1 transactions in Protagonist Therapeutics Inc (PTGX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Protagonist Therapeutics Inc is the acquisition of 8,000 shares on December 3, 2019, which cost Bryan Giraudo around $45,600.
According to the SEC Form 4 filings, Bryan Giraudo has made a total of 11 transactions in Gossamer Bio Inc (GOSS) over the past 5 years, including 8 buys and 3 sells. The most-recent trade in Gossamer Bio Inc is the sale of 6,430 shares on March 27, 2024, which brought Bryan Giraudo around $7,459.
Insider Trading History of Bryan Giraudo
- 1
Bryan Giraudo Trading Performance
GuruFocus tracks the stock performance after each of Bryan Giraudo's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bryan Giraudo is 18.42%. GuruFocus also compares Bryan Giraudo's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bryan Giraudo within 3 months outperforms 7 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bryan Giraudo's insider trading performs compared to the benchmark.
Performance of Bryan Giraudo
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.88 | | | | | |
| Relative Return to S&P 500(%) | 15.04 | | | | | |
Bryan Giraudo Ownership Network
Bryan Giraudo Owned Company Details
What does Gossamer Bio Inc do?
Who are the key executives at Gossamer Bio Inc?
Bryan Giraudo is the Chief Financial Officer of Gossamer Bio Inc. Other key executives at Gossamer Bio Inc include EVP & General Counsel Waage Christian , director & Executive Chairman Faheem Hasnain , and EVP & Regulatory Affairs Caryn Peterson .
Gossamer Bio Inc (GOSS) Insider Trades Summary
Over the past 18 months, Bryan Giraudo made 4 insider transaction in Gossamer Bio Inc (GOSS) with a net purchase of 298,570. Other recent insider transactions involving Gossamer Bio Inc (GOSS) include a net sale of 13,395 shares made by Richard Aranda , a net purchase of 855,400 shares made by Faheem Hasnain , and a net purchase of 12,070 shares made by Waage Christian .
In summary, during the past 3 months, insiders sold 44,068 shares of Gossamer Bio Inc (GOSS) in total and bought 0 shares, with a net sale of 44,068 shares. During the past 18 months, 67,038 shares of Gossamer Bio Inc (GOSS) were sold and 1,234,072 shares were bought by its insiders, resulting in a net purchase of 1,167,034 shares.
Gossamer Bio Inc (GOSS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Gossamer Bio Inc Insider Transactions
Bryan Giraudo Mailing Address
Above is the net worth, insider trading, and ownership report for Bryan Giraudo. You might contact Bryan Giraudo via mailing address: 7707 Gateway Boulevard, Suite 140, Newark Ca 94560.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
